{"name":"AtriCure","slug":"atricure","ticker":"ATRC","exchange":"NASDAQ","domain":"atricure.com","description":"AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single","hq":"Mason, OH","founded":0,"employees":"1350","ceo":"Michael Carrel","sector":"Medical Devices — Cardiac Surgery","stockPrice":29.25,"stockChange":0.36,"stockChangePercent":1.25,"marketCap":"$1.5B","metrics":{"revenue":400000000,"revenueGrowth":13.1,"grossMargin":75,"rdSpend":99209000,"netIncome":-11448000,"cash":167428000,"dividendYield":0,"peRatio":79.1,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"AtriCure Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"AtriCure reported fourth quarter and full year 2023 financial results, with revenue of $93.4 million and $373.8 million, respectively.","drugName":"","sentiment":"neutral"},{"date":"2023-11-07","type":"deal","headline":"AtriCure Announces Agreement with Medtronic to Develop and Commercialize AtriClip Left Atrial Appendage Management System","summary":"AtriCure announced an agreement with Medtronic to develop and commercialize the AtriClip left atrial appendage management system.","drugName":"","sentiment":"positive"},{"date":"2023-08-02","type":"regulatory","headline":"AtriCure Receives FDA Clearance for Harmony Surgical Ablation System","summary":"AtriCure received FDA clearance for the Harmony surgical ablation system, a minimally invasive treatment for atrial fibrillation.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOanJRQUhRM1VvbGp3NVQ1d1VCMkotOE1Nb0hDTWdmVUJoTkswU2xYbXRNTV9EQ2l5WEFwdmRUYm04dFFuTnFod2NHU3NRU0pxaTJzNUFsYlY1TVdLNWdBbzJDYnlGMTNaZWF4RXR6bHVWZ2FRUlVaSFNUdUc5T0xpZHpTZTBfQnJo?oc=5","date":"2026-04-07","type":"pipeline","source":"Moomoo","summary":"AtriCure, Inc. ($ATRC) CEO 2025 Pay Revealed - Moomoo","headline":"AtriCure, Inc. ($ATRC) CEO 2025 Pay Revealed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQYVZfN2txTUQ3cl8zREhfZERsRTFkZnMwS05hZERZRFJRakg4TjNPbzVub1dVMEgzRDNHc21DNlpTUV9kaEFnaXBJUlY4MGt6d3AwaTJ1MXVvXy1pM1FUV1VQMHNKcFBFbTYyVi1oYjJMQmJteE5VclY1UFBaekVmRHJGaDRRLUJLTGxyVVh5TXB6TmwyNEVF?oc=5","date":"2026-04-04","type":"pipeline","source":"Defense World","summary":"AtriCure (NASDAQ:ATRC) Upgraded at Freedom Capital - Defense World","headline":"AtriCure (NASDAQ:ATRC) Upgraded at Freedom Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOVXdIbXlxQUo4UDNZeS0yalRYRDdxOVRERk1vWkt4T3VWUXR5VFZmeXFGMVFPS1M0Mmo3SEYxdlZzSFdqSEpmZlhhcW44TVlTbGNJZEY4YjBFNzNQUGwtT09kbm9FSTVZdDE4Sk1fd0tfM19kYW9kWm1UUVFjYk5IVzg0RmF2dzZFZ1pKZktRUkdVaVJaMXF5TXA0MHY3aC1ubnROeExhUUdxd3d3?oc=5","date":"2026-02-20","type":"pipeline","source":"Kalkine Media","summary":"Is AtriCure (NASDAQ:ATRC) Facing New Pressure In The Nasdaq Index? - Kalkine Media","headline":"Is AtriCure (NASDAQ:ATRC) Facing New Pressure In The Nasdaq Index?","sentiment":"neutral"},{"date":"2026-02-19","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNbFZjR1lxZnVzQlF3UmZDUlpDdzdLbS1WaE5YWFQ1QU9JRmxQTW9XQjZ4NHBxWGkzMWhFYlhkVVlTNEZTMHpoSVdQMlI2eWlxMWVLS0RzM21RV01TUnk2bzg1U0NTQ015SzlxamluWGFBdDA1UFhpaTdCU01ITV9mUHNtRHg4OHdzWl9vbk5SajE5RFZGYnFhbjJIOV93S3FqOGfSAaIBQVVfeXFMTWxWY0dZcWZ1c0JRd1JmQ1JaQ3c3S20tVmhOWFhUNUFPSUZsUE1vV0I2eDRwcVhpMzFoRWJYZFVZUzRGUzB6aElXUDJSNnlpcTFlS0tEczNtUVdNU1J5Nm84NVNDU0NNeUs5cWppblhhQXQwNVBYaWk3QlNNSE1fZlBzbUR4ODh3c1pfb25OUmoxOURWRmJxYW4ySDlfd0txajhn?oc=5","date":"2026-02-17","type":"earnings","source":"AlphaStreet","summary":"AtriCure reports surprise Q4 profit on strong worldwide revenue growth - AlphaStreet","headline":"AtriCure reports surprise Q4 profit on strong worldwide revenue growth","sentiment":"positive"},{"date":"2026-02-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPeTh0Ymw4akFSdm4tb2xic0xhRTB1ZFBSSjV5MmN2UXpjcy1jYXVqRmxITkNvZi1GZWNjRWJxZ0NuSTZteVU5a29yWGNPRC1fXzFhOGZvRTYzT0hGWmNQMWJVYUxXc29DSlJSZV9zNkttVzFRQmpBQ2dEUkFrYXpiQ095UFdoN0oyN1plVkR6a290TGVLRmhWZDRXMFlGeDBPLUdTTzgxQQ?oc=5","date":"2026-02-06","type":"earnings","source":"TradingView","summary":"MCK Q3 Earnings & Sales Top Estimates, 2026 View Up - TradingView","headline":"MCK Q3 Earnings & Sales Top Estimates, 2026 View Up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPLTZRUUM1TmpoTWFJeW1JeXZWRmRlM3VtcVVrY2dZWmdFbGR6TDZ5dEtnTFVXNWxCV2JKVGQ1Z0FjQTZpU0pTdjBiSDg1ZEZuUGExRjA3a2xHMXBqMElqZXdyUGVIV2lWS0N3Q1BaQXdJOExYc1pzZVNwbk1BU3pBbmswQTR3ZkRwaUFIUTdKVW81TWFSLVg1cDFwdEUtSzRkOEpQU0JRQXk1a2tIUk1ITHJ2Yw?oc=5","date":"2026-02-05","type":"earnings","source":"TradingView","summary":"CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains - TradingView","headline":"CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNajkzcjNYX2hKRE81SFB5c3NhOGVqOHgwZ1FOUGRBejZoR29VWVNzVkdseUxwc1BOaGNHRGgwMjBlT2pmUkMyNFF4UTBNUWtBcTk2Qld1M3NoOGJUQ1FUWV9UZ2E2ZFpYRnFrRl9yMWdmYTJMbjNuSzlEbDFZeTdoUXFLSFVHM0kzR25ITHFCbnA3bDJ0LUpZdzBhS21oWmw5d0d4NXNfWXhnUG9xMU5UTjJsU0Z0cVJOUlg4TQ?oc=5","date":"2026-01-12","type":"earnings","source":"Stock Titan","summary":"Afib surgery device maker AtriCure expects to turn a profit in 2026 - Stock Titan","headline":"Afib surgery device maker AtriCure expects to turn a profit in 2026","sentiment":"positive"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPMXlVTm4yejJPZDhOTi1kZjAtNFE4S1VkNVZlWWktN3Q3UThic3RzSFdpM1dhalU4RUk2eUNVV0dFUDFMbk9xUFNpTDJ5SUUwUW1BYkx1cV8wdlJnb29pM0NpRm5pV082NlVJMWlzNmRLVk9DZmN2WUpMNFVnZ08zZVBrZlc5NDNMcEJCSlV1TURmWDJMaWxyX3pqUy0tQk5HNjVkM2dB?oc=5","date":"2026-01-06","type":"pipeline","source":"Kalkine Media","summary":"AtriCure, Inc. (NASDAQ:ATRC) Nasdaq Index Fund Medical Devices - Kalkine Media","headline":"AtriCure, Inc. (NASDAQ:ATRC) Nasdaq Index Fund Medical Devices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPNlBJa0NJS1ZkRjA3bERiV21WTHJCTGt3Z2hQWUszUC0teW0yRHdTTTJLeDJ2T0g1MkN0bWl6Q3M2bENlNnR6Q2R5NlhlVE5VbDhnVm9jdVlCM2NuUHNiemNlWVdRTkxvSGxFNW0wTHV3Y2pySEVna01Md3hRS0I4ZklpQVFMenZPTlh1WnpQV1RsSGY2cGtON3YySWkzTWsyLVVVdURNSmJKQ1lkT0EtckhTaDhmVjgy?oc=5","date":"2025-12-11","type":"pipeline","source":"Stock Titan","summary":"AtriCure (Nasdaq: ATRC) Debuts Dual PFA-RF Surgical Ablation System in First Human Use - Stock Titan","headline":"AtriCure (Nasdaq: ATRC) Debuts Dual PFA-RF Surgical Ablation System in First Human Use","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBVa0xhYVN4eC0xYW9vamVFdTczYXpVdVVuZ2Y2SnVRbDhWMFhxWmNRZnlXMjlhVE41OTZmelNBTFV5R1FUVTZzZWhtVldYeU9I?oc=5","date":"2024-03-09","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Boston Scientific","Medtronic","Abbott Laboratories"],"therapeuticFocus":["Cardiac Surgery","Atrial Fibrillation"],"financials":{"source":"sec_edgar","revenue":201630000,"revenuePeriod":"2018-12-31","revenueHistory":[{"value":201630000,"period":"2018-12-31"},{"value":52893000,"period":"2018-12-31"},{"value":49941000,"period":"2018-09-30"},{"value":51802000,"period":"2018-06-30"},{"value":46994000,"period":"2018-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":99209000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-11448000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":654179000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":29.25,"previousClose":28.89,"fiftyTwoWeekHigh":43.18,"fiftyTwoWeekLow":27.31,"fiftyTwoWeekRange":"27.31 - 43.18","fiftyDayAverage":32.24,"twoHundredDayAverage":34.89,"beta":1.43,"enterpriseValue":1348001024,"forwardPE":79.1,"priceToBook":2.96,"priceToSales":2.77,"enterpriseToRevenue":2.52,"enterpriseToEbitda":121.62,"pegRatio":0,"ebitda":11084000,"ebitdaMargin":2.1,"freeCashflow":38942876,"operatingCashflow":57334000,"totalDebt":76421000,"debtToEquity":15.5,"currentRatio":3.96,"returnOnAssets":-0.9,"returnOnEquity":-2.4,"analystRating":"1.8 - Buy","recommendationKey":"buy","numberOfAnalysts":8,"targetMeanPrice":47.88,"targetHighPrice":54,"targetLowPrice":36,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":3.7,"institutionHeldPercent":101.1,"sharesOutstanding":50634808,"floatShares":47761220,"sharesShort":3414361,"shortRatio":4.63,"shortPercentOfFloat":6.9,"epsTrailing":-0.24,"epsForward":0.37,"revenuePerShare":11.19,"bookValue":9.88,"officers":[{"age":54,"name":"Mr. Michael H. Carrel","title":"CEO, President & Director"},{"age":47,"name":"Ms. Angela L. Wirick","title":"Chief Financial Officer"},{"age":59,"name":"Mr. Douglas J. Seith","title":"Chief Operating Officer"},{"age":55,"name":"Mr. Karl S. Dahlquist CCEP, J.D.","title":"Chief Legal Officer"},{"age":47,"name":"Mr. Justin J. Noznesky","title":"Chief Marketing & Strategy Officer"},{"age":58,"name":"Mr. Salvatore  Privitera J.D.","title":"Chief Technical Officer"},{"age":52,"name":"Dr. Vinayak  Doraiswamy Ph.D.","title":"Chief Scientific Officer"},{"age":null,"name":"Valerie  Storch-Willhaus","title":"Vice President of Corporate Marketing & Communications"}],"industry":"Medical Instruments & Supplies","irWebsite":"","website":"https://www.atricure.com","phone":"513 755 4100"}}